LFCR
Lifecore Biomedical Inc.
NASDAQ: LFCR · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$5.07
+2.63% today
Updated 2026-04-30
Market cap
$190.38M
P/E ratio
—
P/S ratio
1.47x
EPS (TTM)
$-1.27
Dividend yield
—
52W range
$4 – $9
Volume
0.4M
Lifecore Biomedical Inc. (LFCR) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
4 of 8
Last 8 quarters
Avg EPS surprise
+36.5%
Last 4 quarters
Revenue YoY growth
+26.3%
Most recent quarter
EPS YoY growth
+66.0%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-12.3%
Last 3 reports
Positive reaction rate
33%
1 of 3 quarters
Largest single-day move
-33.3%
2026-03-16
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-16 | $-0.16 | +0.0% | $6.54 | $4.36 | -33.3% |
| 2026-01-01 | $0.00 | +100.0% | $8.18 | $7.80 | -4.6% |
| 2025-11-06 | $-0.29 | +9.4% | $6.77 | $6.85 | +1.2% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2026-02-28 | $-0.16 | $-0.16 | +0.0% | $44.41M | +26.3% |
| 2025-11-30 | $-0.16 | $0.00 | +100.0% | — | — |
| 2025-08-31 | $-0.32 | $-0.29 | +9.4% | $31.11M | +25.9% |
| 2025-05-31 | $-0.04 | $-0.06 | -71.4% | $36.44M | -3.8% |
| 2025-02-28 | $-0.14 | $-0.47 | -228.0% | $35.15M | +37.7% |
| 2024-11-30 | $-0.27 | $-0.25 | +7.4% | $32.56M | +8.0% |
| 2024-08-31 | $-0.46 | $-0.49 | -6.5% | $24.70M | +0.7% |
| 2024-05-31 | $-0.12 | $-0.17 | -41.7% | $37.89M | +42.8% |
| 2024-02-29 | $0.13 | $0.42 | +223.1% | $25.52M | — |
| 2023-11-30 | $-0.23 | $-0.13 | +43.5% | $30.15M | — |
| 2023-08-31 | $-0.23 | $-1.19 | -418.1% | $24.52M | — |
| 2023-05-31 | $-0.37 | $-0.89 | -140.5% | $26.54M | — |
Frequently asked questions
Has Lifecore Biomedical Inc. beaten earnings estimates?
Lifecore Biomedical Inc. has beaten Wall Street EPS estimates in 4 of its last 8 quarterly reports, with an average EPS surprise of +36.5% over the last 3 quarters.
How does LFCR stock react to earnings?
LFCR stock has moved an average of -12.3% in the trading day following earnings over its last 3 reports, with positive reactions in 33% of those quarters.
What is Lifecore Biomedical Inc.'s revenue growth rate?
Lifecore Biomedical Inc. reported year-over-year revenue growth of +26.3% in its most recent quarter, with EPS growing +66.0% year-over-year.